Kimberly Ha/LinkedIn
Apr 3, 2026, 17:33
Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
Kimberly Ha, Founder and CEO at KKH Advisors, shared a post on LinkedIn:
”Epia Neuro is the latest medtech startup looking to tap the potential of brain-computer interface (BCI) technology, launching with a device that aims to turn brain signals into digital commands.
The San Francisco-based company is focusing its neural interface platform initially on stroke survivors.
The platform combines a minimally invasive, long-lifetime read/write brain-computer interface (pictured above) with assistive devices and AI-driven support, aiming to help stroke survivors translate neural signals into functional movement, according to an April 2 release.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests